These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 30602512)

  • 1. Rufomycin Targets ClpC1 Proteolysis in Mycobacterium tuberculosis and M. abscessus.
    Choules MP; Wolf NM; Lee H; Anderson JR; Grzelak EM; Wang Y; Ma R; Gao W; McAlpine JB; Jin YY; Cheng J; Lee H; Suh JW; Duc NM; Paik S; Choe JH; Jo EK; Chang CL; Lee JS; Jaki BU; Pauli GF; Franzblau SG; Cho S
    Antimicrob Agents Chemother; 2019 Mar; 63(3):. PubMed ID: 30602512
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-Resolution Structure of ClpC1-Rufomycin and Ligand Binding Studies Provide a Framework to Design and Optimize Anti-Tuberculosis Leads.
    Wolf NM; Lee H; Choules MP; Pauli GF; Phansalkar R; Anderson JR; Gao W; Ren J; Santarsiero BD; Lee H; Cheng J; Jin YY; Ho NA; Duc NM; Suh JW; Abad-Zapatero C; Cho S
    ACS Infect Dis; 2019 Jun; 5(6):829-840. PubMed ID: 30990022
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The cyclic peptide ecumicin targeting ClpC1 is active against Mycobacterium tuberculosis in vivo.
    Gao W; Kim JY; Anderson JR; Akopian T; Hong S; Jin YY; Kandror O; Kim JW; Lee IA; Lee SY; McAlpine JB; Mulugeta S; Sunoqrot S; Wang Y; Yang SH; Yoon TM; Goldberg AL; Pauli GF; Suh JW; Franzblau SG; Cho S
    Antimicrob Agents Chemother; 2015 Feb; 59(2):880-9. PubMed ID: 25421483
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Crystal structure of the N-terminal domain of MtClpC1 in complex with the anti-mycobacterial natural peptide Lassomycin.
    Jagdev MK; Tompa DR; Ling LL; Peoples AJ; Dandapat J; Mohapatra C; Lewis K; Vasudevan D
    Int J Biol Macromol; 2023 Dec; 253(Pt 2):126771. PubMed ID: 37683752
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure of the N-terminal domain of ClpC1 in complex with the antituberculosis natural product ecumicin reveals unique binding interactions.
    Wolf NM; Lee H; Zagal D; Nam JW; Oh DC; Lee H; Suh JW; Pauli GF; Cho S; Abad-Zapatero C
    Acta Crystallogr D Struct Biol; 2020 May; 76(Pt 5):458-471. PubMed ID: 32355042
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antimycobacterial Rufomycin Analogues from
    Zhou B; Shetye G; Yu Y; Santarsiero BD; Klein LL; Abad-Zapatero C; Wolf NM; Cheng J; Jin Y; Lee H; Suh JW; Lee H; Bisson J; McAlpine JB; Chen SN; Cho SH; Franzblau SG; Pauli GF
    J Nat Prod; 2020 Mar; 83(3):657-667. PubMed ID: 32031795
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of the inhibitory mechanism of ecumicin and rufomycin 4-7 on the proteolytic activity of Mycobacterium tuberculosis ClpC1/ClpP1/ClpP2 complex.
    Hong J; Duc NM; Jeong BC; Cho S; Shetye G; Cao J; Lee H; Jeong C; Lee H; Suh JW
    Tuberculosis (Edinb); 2023 Jan; 138():102298. PubMed ID: 36580851
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biosynthetic Interrogation of Soil Metagenomes Reveals Metamarin, an Uncommon Cyclomarin Congener with Activity against
    Li L; MacIntyre LW; Ali T; Russo R; Koirala B; Hernandez Y; Brady SF
    J Nat Prod; 2021 Apr; 84(4):1056-1066. PubMed ID: 33621083
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutation analysis of the interactions between Mycobacterium tuberculosis caseinolytic protease C1 (ClpC1) and ecumicin.
    Jung IP; Ha NR; Kim AR; Kim SH; Yoon MY
    Int J Biol Macromol; 2017 Aug; 101():348-357. PubMed ID: 28342755
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence for Inhibition of Topoisomerase 1A by Gold(III) Macrocycles and Chelates Targeting Mycobacterium tuberculosis and Mycobacterium abscessus.
    Gupta R; Rodrigues Felix C; Akerman MP; Akerman KJ; Slabber CA; Wang W; Adams J; Shaw LN; Tse-Dinh YC; Munro OQ; Rohde KH
    Antimicrob Agents Chemother; 2018 May; 62(5):. PubMed ID: 29483110
    [No Abstract]   [Full Text] [Related]  

  • 11. Bedaquiline Inhibits the ATP Synthase in Mycobacterium abscessus and Is Effective in Infected Zebrafish.
    Dupont C; Viljoen A; Thomas S; Roquet-Banères F; Herrmann JL; Pethe K; Kremer L
    Antimicrob Agents Chemother; 2017 Nov; 61(11):. PubMed ID: 28807917
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The antibiotic cyclomarin blocks arginine-phosphate-induced millisecond dynamics in the N-terminal domain of ClpC1 from
    Weinhäupl K; Brennich M; Kazmaier U; Lelievre J; Ballell L; Goldberg A; Schanda P; Fraga H
    J Biol Chem; 2018 Jun; 293(22):8379-8393. PubMed ID: 29632076
    [No Abstract]   [Full Text] [Related]  

  • 13. Mechanism and resistance for antimycobacterial activity of a fluoroquinophenoxazine compound.
    Garcia PK; Annamalai T; Wang W; Bell RS; Le D; Martin Pancorbo P; Sikandar S; Seddek A; Yu X; Sun D; Uhlemann AC; Tiwari PB; Leng F; Tse-Dinh YC
    PLoS One; 2019; 14(2):e0207733. PubMed ID: 30794538
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-tuberculosis lead molecules from natural products targeting Mycobacterium tuberculosis ClpC1.
    Lee H; Suh JW
    J Ind Microbiol Biotechnol; 2016 Mar; 43(2-3):205-12. PubMed ID: 26586403
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Active Benzimidazole Derivatives Targeting the MmpL3 Transporter in
    Raynaud C; Daher W; Johansen MD; Roquet-Banères F; Blaise M; Onajole OK; Kozikowski AP; Herrmann JL; Dziadek J; Gobis K; Kremer L
    ACS Infect Dis; 2020 Feb; 6(2):324-337. PubMed ID: 31860799
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure of the drug target ClpC1 unfoldase in action provides insights on antibiotic mechanism of action.
    Weinhäupl K; Gragera M; Bueno-Carrasco MT; Arranz R; Krandor O; Akopian T; Soares R; Rubin E; Felix J; Fraga H
    J Biol Chem; 2022 Nov; 298(11):102553. PubMed ID: 36208775
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting mycobacterial proteolytic complexes with natural products.
    Parish T
    Chem Biol; 2014 Apr; 21(4):437-438. PubMed ID: 24766844
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lassomycin, a ribosomally synthesized cyclic peptide, kills mycobacterium tuberculosis by targeting the ATP-dependent protease ClpC1P1P2.
    Gavrish E; Sit CS; Cao S; Kandror O; Spoering A; Peoples A; Ling L; Fetterman A; Hughes D; Bissell A; Torrey H; Akopian T; Mueller A; Epstein S; Goldberg A; Clardy J; Lewis K
    Chem Biol; 2014 Apr; 21(4):509-518. PubMed ID: 24684906
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Verapamil Improves the Activity of Bedaquiline against Mycobacterium abscessus In Vitro and in Macrophages.
    Viljoen A; Raynaud C; Johansen MD; Roquet-Banères F; Herrmann JL; Daher W; Kremer L
    Antimicrob Agents Chemother; 2019 Sep; 63(9):. PubMed ID: 31209005
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pulmonary disease due to Mycobacterium massiliense.
    Mitra S; Tapadar SR; Banerjee D; Bhattacharjee S; Dey S; Kundu S
    Indian J Chest Dis Allied Sci; 2012; 54(1):53-7. PubMed ID: 22779125
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.